CSIMarket Company Name, Ticker, Customers, else..


Jazz Pharmaceuticals Plc  (NASDAQ: JAZZ)
Other Ticker:  
 

Jazz Pharmaceuticals Plc

JAZZ's Fundamental analysis



Jazz Pharmaceuticals Plc's sales fell by -0.46 % in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 1063

Major Pharmaceutical Preparations industry recorded growth of revenues by 4.5 %

Jazz Pharmaceuticals Plc net loss increased from $-15 millions, to $-93 millions in first quarter of 2025,

• More on JAZZ's Growth


Jazz Pharmaceuticals Plc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Jazz Pharmaceuticals Plc PEG ratio is at 0.23 Company is currently trading with Price to Cash flow multiple of 15.77 in trailing twelve-month period.
Company
14.35
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.62.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.17.


• More on JAZZ's Valuation
 
 Total Debt (Millions $) 5,367
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,451,717
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 5.82
 Tangible Book Value (Per Share $) -37.77

Jazz Pharmaceuticals Plc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Jazz Pharmaceuticals Plc PEG ratio is at 0.23 Company is currently trading with Price to Cash flow multiple of 15.77 in trailing twelve-month period.
Company
14.35
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.62.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.17.

Jazz Pharmaceuticals Plc Price to Book Ratio is at 1.58 lower than Industry Avg. of 33.1. and higher than S&P 500 Avg. of 0.01

• More on JAZZ's Valuation

•  Market Capitalization (Millions $) 6,602
•  Shares Outstanding (Millions) 61
•  Employees 2,800
•  Revenues (TTM) (Millions $) 4,065
•  Net Income (TTM) (Millions $) 482
•  Cash Flow (TTM) (Millions $) 419
•  Capital Exp. (TTM) (Millions $) -70
•  Total Debt (Millions $) 5,367
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 1,451,717
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 5.82
•  Tangible Book Value (Per Share $) -37.77

•  Market Capitalization (Millions $) 6,602
•  Shares Outstanding (Millions) 61
•  Employees 2,800
•  Revenues (TTM) (Millions $) 4,065
•  Net Income (TTM) (Millions $) 482
•  Cash Flow (TTM) (Millions $) 419
•  Capital Exp. (TTM) (Millions $) -70





  Ratio
•   Capital Ratio (MRQ) 3.38
•  Total Debt to Equity (MRQ) 1.29
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.36
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com